Lease Agreements in the Pharmaceuticals Industry

825 Contracts & Agreements

Browse by Company

Acacia Diversified Holdings, Inc. (2 contracts)
ACELRX PHARMACEUTICALS INC (5)
Acer Therapeutics Inc. (7)
ACHILLION PHARMACEUTICALS INC (7)
Aclaris Therapeutics, Inc. (4)
Adamis Pharmaceuticals Corp (4)
ADIAL PHARMACEUTICALS, INC. (1)
Aegerion Pharmaceuticals, Inc. (9)
Aerpio Pharmaceuticals, Inc. (3)
AGILE THERAPEUTICS INC (5)
Akorn (3)
ALDER BIOPHARMACEUTICALS INC (5)
Alexza Pharmaceuticals Inc. (1)
ALGORX PHARMACEUTICALS INC (1)
ALIMERA SCIENCES INC (2)
ALSERES PHARMACEUTICALS INC (2)
Altus Pharmaceuticals Inc. (9)
Amag Pharmaceuticals (10)
AmeriCann, Inc. (5)
Ampio Pharmaceuticals, Inc. (3)
AMYLIN PHARMACEUTICALS INC (2)
Amylyx Pharmaceuticals, Inc. (1)
Anacor Pharmaceuticals, Inc. (4)
ANADYS PHARMACEUTICALS INC (2)
Anebulo Pharmaceuticals, Inc. (1)
Angion Biomedica Corp. (3)
ANI Pharma Inc (8)
Anthera Pharmaceuticals Inc (2)
APP Pharmaceuticals, Inc. (5)
Aquestive Therapeutics, Inc. (1)
ARADIGM CORP (1)
Aralez Pharmaceuticals Inc. (2)
ARIAD PHARMACEUTICALS INC (8)
ARVINAS, INC. (10)
Assertio Therapeutics, Inc (12)
Atea Pharmaceuticals, Inc. (3)
Athira Pharma, Inc. (2)
Auspex Pharmaceuticals, Inc. (5)
AUXILIUM PHARMACEUTICALS INC (3)
AVADEL PHARMACEUTICALS PLC (3)
AVANIR PHARMACEUTICALS, INC. (8)
AYTU BIOSCIENCE, INC (1)
BARR PHARMACEUTICALS INC (1)
Barrel Energy Inc. (1)
BioNumerik Pharmaceuticals, Inc. (2)
BioPharmX Corp (6)
Blue Water Acquisition Corp. (1)
BODY & MIND INC. (3)
Bohai Pharmaceuticals Group, Inc. (1)
CADENCE PHARMACEUTICALS INC (3)
Canbiola, Inc. (4)
CANNAPHARMARX, INC. (1)
Cara Therapeutics, Inc. (3)
CASSAVA SCIENCES INC (6)
Celator Pharmaceuticals Inc (2)
Cerecor Inc. (2)
CHIASMA, INC (7)
CHINA PEDIATRIC PHARMACEUTICALS, INC. (1)
Clearside Biomedical, Inc. (2)
CLS Holdings USA, Inc. (10)
COGNITION THERAPEUTICS INC (4)
COLLEGIUM PHARMACEUTICAL, INC (4)
Corcept Therapeutics Incorporated (8)
COSMO VENTURES INC (1)
CUBIST PHARMACEUTICALS INC (7)
CUMBERLAND PHARMACEUTICALS INC (8)
Cure Pharmaceutical Holding Corp. (1)
CymaBay Therapeutics, Inc. (2)
Cyteir Therapeutics, Inc. (2)
DiCE MOLECULES HOLDINGS, LLC (4)
Dova Pharmaceuticals Inc. (3)
DURECT CORP (20)
Edgewise Therapeutics, Inc. (1)
Egalet Corp (1)
Elixir Pharmaceuticals, Inc. (3)
Eloxx Pharmaceuticals, Inc. (5)
ENCYSIVE PHARMACEUTICALS INC (1)
EPIX Pharmaceuticals, Inc. (6)
Evofem Biosciences, Inc. (6)
Evoke Pharma Inc (6)
Evolus, Inc. (3)
Exactus, Inc. (3)
EyePoint Pharmaceuticals, Inc. (5)
EYETECH PHARMACEUTICALS INC (4)
Foamix Pharmaceuticals Ltd. (4)
Fulcrum Therapeutics, Inc. (1)
Furiex Pharmaceuticals, Inc. (1)
GRAYBUG VISION, INC. (2)
GUILFORD PHARMACEUTICALS INC (2)
HARROW HEALTH, INC. (1)
Horizon Pharma plc (9)
IDENIX PHARMACEUTICALS INC (10)
Ikena Oncology, Inc. (1)
IMAGING3 INC (1)
IMARA Inc. (3)
INNOVATE BIOPHARMACEUTICALS, INC. (1)
Innoviva, Inc. (5)
INSPIRE PHARMACEUTICALS INC (4)
Intersect ENT, Inc. (4)
ISTA PHARMACEUTICALS INC (5)
Jaguar Health, Inc. (8)
JAVELIN PHARMACEUTICALS, INC (2)
Jazz Pharmaceuticals plc (7)
JUNIPER PHARMACEUTICALS INC (2)
Jushi Holdings Inc. (10)
Kala Pharmaceuticals, Inc. (2)
Kaleido Biosciences, Inc. (2)
Kaya Holdings, Inc. (5)
KEMPHARM, INC (4)
Lev Pharmaceuticals Inc (1)
Level Brands, Inc. (4)
Lexaria Bioscience Corp. (2)
LIPELLA PHARMACEUTICALS INC (3)
Lipocine Inc. (2)
Liquidia Technologies Inc (2)
Lumena Pharmaceuticals, Inc. (1)
Lyra Therapeutics, Inc. (2)
MAP Pharmaceuticals, Inc. (7)
MARINUS PHARMACEUTICALS INC (2)
MAXIM PHARMACEUTICALS INC (1)
Medicine Man Technologies, Inc. (1)
Menlo Therapeutics Inc. (2)
MICROCHANNEL TECHNOLOGIES CORP (7)
MiddleBrook Pharmaceuticals, Inc. (2)
MILLENNIUM PHARMACEUTICALS INC (1)
MIRA PHARMACEUTICALS, INC. (1)
MJ BIOTECH, INC. (1)
MJ Holdings, Inc. (6)
Molecular Insight Pharmaceuticals, Inc. (6)
MYnd Analytics, Inc. (2)
MyoKardia Inc (4)
Nabriva Therapeutics plc (2)
NEKTAR THERAPEUTICS (3)
Neuralstem, Inc. (2)
NEW RIVER PHARMACEUTICALS INC (8)
NGM BIOPHARMACEUTICALS INC (1)
Notis Global, Inc. (1)
NovaBay Pharmaceuticals, Inc. (7)
Novan, Inc. (7)
NPS PHARMACEUTICALS INC (8)
NUCRYST Pharmaceuticals Corp. (2)
OCULAR THERAPEUTIX, INC (5)
OMEROS CORP (16)
Omthera Pharmaceuticals, Inc. (1)
OncoMed Pharmaceuticals Inc (4)
One World Pharma, Inc. (5)
OPIANT PHARMACEUTICALS, INC. (1)
OPTIMER PHARMACEUTICALS INC (5)
OSCIENT PHARMACEUTICALS CORP (1)
OTONOMY, INC. (4)
Pacira Pharmaceuticals, Inc. (3)
Panacea Acquisition Corp (1)
PANACOS PHARMACEUTICALS, INC. (3)
Paratek Pharmaceuticals, Inc. (18)
PEAK PHARMACEUTICALS, INC. (1)
PENWEST PHARMACEUTICALS CO (3)
PLIANT THERAPEUTICS, INC. (1)
PLx Pharma Inc. (5)
PONIARD PHARMACEUTICALS, INC. (5)
PRAECIS PHARMACEUTICALS INC (1)
PREDIX PHARMACEUTICALS HOLDINGS INC (5)
Prestige Brands Holdings Inc (2)
Processa Pharmaceuticals, Inc. (1)
Profile Solutions, Inc. (1)
ProPhase Labs, Inc. (3)
Pulmatrix, Inc. (1)
QUARK PHARMACEUTICALS INC (4)
Ra Pharmaceuticals, Inc. (1)
Rain Therapeutics Inc. (3)
REATA PHARMACEUTICALS INC (6)
Recro Pharma, Inc. (1)
Reliant Pharmaceuticals, Inc. (2)
RELMADA THERAPEUTICS, INC. (2)
RespireRx Pharmaceuticals Inc. (2)
resTORbio, Inc. (15)
Revance Therapeutics, Inc. (7)
Rib-X Pharmaceuticals, Inc. (1)
ROCK CREEK PHARMACEUTICALS, INC. (1)
SALIX PHARMACEUTICALS LTD (4)
SANCILIO PHARMACEUTICALS COMPANY, INC. (3)
Satsuma Pharmaceuticals, Inc. (1)
SAVIENT PHARMACEUTICALS INC (2)
scPharmaceuticals Inc. (3)
SenesTech, Inc. (5)
SHAMAN PHARMACEUTICALS INC (2)
Sienna Biopharmaceuticals, Inc. (2)
SIGA TECHNOLOGIES INC (5)
Sirtris Pharmaceuticals, Inc. (1)
Sonoma Pharmaceuticals, Inc. (8)
Strongbridge Biopharma plc (1)
Sucampo Pharmaceuticals, Inc. (5)
Supernus Pharmaceuticals, Inc. (10)
TAPESTRY PHARMACEUTICALS, INC (1)
Targeted Medical Pharma, Inc. (1)
Tarsus Pharmaceuticals, Inc. (2)
TAURIGA SCIENCES, INC. (1)
Terns Pharmaceuticals, Inc. (2)
Terra Tech Corp. (1)
TETRAGENEX PHARMACEUTICALS, INC. (1)
TETRALOGIC PHARMACEUTICALS CORP (1)
TETRAPHASE PHARMACEUTICALS INC (5)
TFF Pharmaceuticals, Inc. (1)
THAR PHARMACEUTICALS INC (1)
The Medicines Company (4)
TherapeuticsMD, Inc. (4)
Theravance Biopharma, Inc. (2)
Theseus Pharmaceuticals, Inc. (1)
TITAN PHARMACEUTICALS INC (3)
Trevi Therapeutics, Inc. (1)
Tricida, Inc. (4)
United Cannabis Corp (1)
Urigen Pharmaceuticals, Inc. (2)
Urovant Sciences Ltd. (1)
Valera Pharmaceuticals Inc (3)
Vallon Pharmaceuticals, Inc. (1)
Ventyx Biosciences, Inc. (4)
Verona Pharma plc (3)
Verrica Pharmaceuticals Inc. (4)
Viamet Pharmaceuticals Holdings LLC (1)
Vireo Health International, Inc. (3)
Vitae Pharmaceuticals, Inc (1)
Vitality Biopharma, Inc. (3)
VIVUS INC (6)
Wave Life Sciences Ltd. (8)
XANODYNE PHARMACEUTICALS INC (1)
XERIS PHARMACEUTICALS INC (2)
ZOGENIX, INC. (2)
Zomedica Pharmaceuticals Corp. (9)
Zynerba Pharmaceuticals, Inc. (5)

Recent Contracts

Sublease Agreement, dated as of August 31, 2023, by and between scPharmaceuticals Inc. and 89 Degrees, Inc. (d/b/a Iris Concise) (scPharmaceuticals Inc., Filed With SEC on September 20, 2023)
Addendum IV to Lease between the Company and Wescove Vacaville, LLC dated as of May 11, 2023 (DURECT CORP, Filed With SEC on August 10, 2023)
Fourth Amendment to Lease, dated as of August 7, 2023, by and between Adicet Therapeutics, Inc. as Tenant, and Westport Office Park, LLC as Landlord (resTORbio, Inc., Filed With SEC on August 9, 2023)
Fourth Amendment to Sublease Agreement, dated as of May 31, 2023, between Avadel Management Corporation and R.G. Brinkmann Company (AVADEL PHARMACEUTICALS PLC, Filed With SEC on August 9, 2023)
Amendment No. 2 to Lease Agreement dated October 15, 2019, as amended by the First Amendment to Lease Agreement, dated May 27, 2020 (REATA PHARMACEUTICALS INC, Filed With SEC on August 8, 2023)
Lease Agreement made by and between Lipella Pharmaceuticals Inc. and Bridgeway Development Corporation, executed on July 27, 2023 (LIPELLA PHARMACEUTICALS INC, Filed With SEC on August 2, 2023)
Sublease Agreement, dated July 21, 2023, by and between the Company and Neurocrine Biosciences (Ventyx Biosciences, Inc., Filed With SEC on July 26, 2023)
Agreement for Shared Lease Costs, dated April 1, 2023, between MIRA Pharmaceuticals, Inc., Telomir Pharmaceuticals, Inc., and MIRALOGX, LLC (MIRA PHARMACEUTICALS, INC., Filed With SEC on July 14, 2023)
Seventh Amendment to Lease, dated July 12, 2023, by and between Lyra Therapeutics, Inc. and ARE-480 Arsenal Street, LLC (Lyra Therapeutics, Inc., Filed With SEC on July 14, 2023)
Third Amendment to Lease, by and between Ocular Therapeutix, Inc. and Cobalt PropCo 2020, LLC, dated June 30, 2023 (OCULAR THERAPEUTIX, INC, Filed With SEC on July 7, 2023)
First Amendment to Multi-Tenant Industrial Triple Net Lease entered into as of May 10, 2023 by and between ULF Northfield Business Center LL and Zomedica Inc (Zomedica Pharmaceuticals Corp., Filed With SEC on May 11, 2023)
Third Amendment to Office Lease Agreement, dated March 16, 2023, between the Registrant and BSP Senita 8000 Jarvis, LLC (Rain Therapeutics Inc., Filed With SEC on May 11, 2023)
Third Amendment to Lease dated January 13, 2023, by and between Revance Therapeutics, Inc. and 1222 Demonbreun, LP (Revance Therapeutics, Inc., Filed With SEC on May 9, 2023)
Sublease Agreement entered into February 16, 2023 but effective March 1, 2023 by and between Ampio Pharmaceuticals, Inc. and Utility Global, Inc (Ampio Pharmaceuticals, Inc., Filed With SEC on May 8, 2023)
Eighth Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of April 1, 2023 (Corcept Therapeutics Incorporated, Filed With SEC on May 3, 2023)
Fourth Amendment to Lease Agreement, dated February 24, 2023, by and between IIP-NY 2 LLC and Vireo Health of New York, LLC (Vireo Health International, Inc., Filed With SEC on March 31, 2023)
Lease Agreement, dated February 8, 2023, by and between Timber Pharmaceuticals, Inc. and Paulus, Sokolowski and Sartor, LLC (BioPharmX Corp, Filed With SEC on March 31, 2023)
Fifth Amendment to Lease Agreement between IIP-MN 1 LLC and Minnesota Medical Solutions, LLC, dated February 24, 2023 (Vireo Health International, Inc., Filed With SEC on March 31, 2023)
Second Amendment to Office Lease Agreement, dated October 4, 2022, between the Registrant and BSP Senita 8000 Jarvis, LLC (Rain Therapeutics Inc., Filed With SEC on March 9, 2023)
Lease Termination Agreement, dated December 23, 2022 (OTONOMY, INC., Filed With SEC on December 29, 2022)
Lease Agreement, dated as of March 2, 2018, by and between La Jolla Shores Plaza, LLC and GRI Bio, Inc., for that property located at 2223 Avenida de la Playa, Suite 208, La... (Vallon Pharmaceuticals, Inc., Filed With SEC on December 23, 2022)
Form of Lease Agreement to be entered into by and between Societal CDMO Gainesville, LLC and Tenet Equity Funding SPE Gainesville, LLC (Recro Pharma, Inc., Filed With SEC on December 12, 2022)
Amendment No. 2 to Lease Agreement between Bridgeway Development Corporation and Lipella Pharmaceuticals Inc. dated July 2, 2020 (LIPELLA PHARMACEUTICALS INC, Filed With SEC on November 28, 2022)
Lease dated June 1, 2019 between Bridgeway Development Corporation and Lipella Pharmaceuticals Inc (LIPELLA PHARMACEUTICALS INC, Filed With SEC on November 28, 2022)
Sixth Amendment to Lease, dated November 14, 2022, by and between Lyra Therapeutics, Inc. and ARE-480 Arsenal Street, LLC (Lyra Therapeutics, Inc., Filed With SEC on November 16, 2022)
Lease Agreement, effective July 1, 2022 by and between Zomedica Inc. and Lebow 1031 Legacy, LLC (Zomedica Pharmaceuticals Corp., Filed With SEC on November 14, 2022)
First Amendment to Lease between 101 College Street, LLC and Arvinas Operations, Inc., dated August 5, 2022 (ARVINAS, INC., Filed With SEC on November 9, 2022)
First Amendment to Lease Agreement for Processa Pharmaceuticals, Inc (Processa Pharmaceuticals, Inc., Filed With SEC on November 8, 2022)
Office Lease Agreement, dated August 31, 2022 (COGNITION THERAPEUTICS INC, Filed With SEC on November 7, 2022)
Lease Agreement by and between 9 Meters Biopharma, Inc. and Crabtree Terrace Holdings LLC, dated October 3, 2022 (INNOVATE BIOPHARMACEUTICALS, INC., Filed With SEC on October 6, 2022)
Sublease Agreement, dated August 15, 2020, as amended on August 1, 2022, between Anebulo Pharmaceuticals, Inc. and JFL Capital Management LLC (Anebulo Pharmaceuticals, Inc., Filed With SEC on September 9, 2022)
Lease Agreement, effective April 1, 2022, by and between Zomedica Inc. and ULF Northfield Business Center (Zomedica Pharmaceuticals Corp., Filed With SEC on August 15, 2022)
First Amendment dated July 14, 2022 to the Office Lease Between AP Beacon Carlsbad, LP, and Palisade Bio, Inc., dated May 12, 2022 (Neuralstem, Inc., Filed With SEC on August 15, 2022)
Lease by and between Charlotta Partners, Inc. and the Company, dated April 25, 2022 (Ventyx Biosciences, Inc., Filed With SEC on August 15, 2022)
Office Sublease, dated as of May 27, 2022, by and between Evofem Biosciences, Inc. and AMN Healthcare, Inc (Evofem Biosciences, Inc., Filed With SEC on August 12, 2022)
Second Amendment (to Lease) by and between Wave Life Sciences USA, Inc. and CPI/King 733 Concord Owner, LLC, dated as of August 8, 2022 (Wave Life Sciences Ltd., Filed With SEC on August 11, 2022)
Second Amendment to Lease, dated as of June 16, 2022, between Adicet Therapeutics, Inc. as Tenant, and Westport Office Park, LLC, as Landlord (incorporated by reference to Exhibit... (resTORbio, Inc., Filed With SEC on August 10, 2022)
Amendment to Sublease Agreement dated April 11, 2022 between the Company and DataRobot, Inc (Atea Pharmaceuticals, Inc., Filed With SEC on August 8, 2022)
Second Amendment and Termination of Office Lease Agreement, effective July 21, 2022, between the Registrant and Columbia REIT 116 Huntington, LLC (IMARA Inc., Filed With SEC on July 29, 2022)
Second Amendment to Lease, dated January 12, 2022, by and between TAC Vega MA Owner, LLC and Valiant Enterprises, LLC (Jushi Holdings Inc., Filed With SEC on July 22, 2022)